Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (HKG:6990)
Hong Kong
· Delayed Price · Currency is HKD 285.40
-3.60 (-1.25%)
At close: Apr 17, 2025, 4:00 PM HKT
HKG:6990 Revenue
In the year 2024, Sichuan Kelun-Biotech Biopharmaceutical had annual revenue of 1.93B CNY with 25.48% growth. Sichuan Kelun-Biotech Biopharmaceutical had revenue of 550.25M in the half year ending December 31, 2024, with 19.90% growth.
Revenue
1.93B CNY
Revenue Growth
+25.48%
P/S Ratio
34.05
Revenue / Employee
1.31M CNY
Employees
1,477
Market Cap
70.04B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.93B | 392.55M | 25.48% |
| Dec 31, 2023 | 1.54B | 736.56M | 91.62% |
| Dec 31, 2022 | 803.93M | 771.61M | 2,387.26% |
| Dec 31, 2021 | 32.32M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition